Cancer & Therapeutics

Cancer Therapeutics aims to address the challenges of tumour heterogeneity, cancer development, and drug resistance by utilising a growing number of technologies available to doctors in the treatment of this illness. It has gone through a paradigm shift away from classic cytotoxic medications and toward targeting proteins that are fundamental to the cancer phenotype. The discovery and development of HSP90 inhibitors has been sought by cancer therapies as a means of avoiding or overcoming medication resistance. All anticancer drugs work by inhibiting cell growth or normal function, DNA synthesis, and RNA and protein metabolite blocking or alteration.

  • Cancer stem cells
  • Kinase inhibitors
  • Personalised medicine
  • Protein–protein interactions

    Related Conference of Cancer & Therapeutics

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Cancer & Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in